Resolution In Support of the PhRMA Code and Corporate Self-Regulation
WHEREAS, Health care is an expanding portion of state budgets; and
WHEREAS, Prescription medicines, which comprise only 10 cents per health care dollar spent, are being used more frequently to treat diseases, including chronic diseases, and
WHEREAS, Prescription medicines have an essential role in treating chronic diseases, as do changes in personal behavior, such as diet and exercise; and
WHEREAS, America’s pharmaceutical companies are responsible for the discovery and development of the majority of new medicines available to patients in the United States and worldwide each year; and
WHEREAS, New medicines save lives, improve health, and reduce many health care costs, and
WHEREAS, Pharmaceutical companies have the most current information about all aspects of their medicines, and
WHEREAS, Providers need to make decisions based on their knowledge of both medicines and individual patients, and
WHEREAS, Patients and providers need the assurance that providers have the most current information about treatment options to make the best decisions about what specific medicine to prescribe for which patient; and
WHEREAS, ALEC believes that the private sector will provide the most patient-centered, efficient, innovative health care for Americans, and
WHEREAS, PhRMA has adopted a revised Code on Interactions with Healthcare Professionals that explicitly affirms that pharmaceutical company “interactions with healthcare professionals are professional exchanges designed to benefit patients and to enhance the practice of medicine”; and
WHEREAS, PhRMA has provided a mechanism by which physicians, patients, and the general public can confirm whether an individual pharmaceutical company has agreed to abide by the PhRMA Code on Interactions with Healthcare Professionals; and
WHEREAS, PhRMA Code on Interactions with Healthcare Professionals encourages companies to seek external verification that the company has policies and procedures in place to foster compliance with the Code.
NOW THEREFORE BE IT RESOLVED THAT ALEC endorses the new PhRMA Code and commends PhRMA for its adoption of both the Code and the public system for identifying companies that have agreed to abide by the Code.
Approved by ALEC Board of Directors on January 14, 2009.
Re-approved January 9, 2014..